title: [Cephalic pancreaticoduodenectomy for adenocarcinoma of the head of the pancreas: does pylorus preservation change morbidity and prognosis?].
abstract: OBJECTIVE
  To evaluate the influence of a pylorus-preserving on the morbidity and prognosis of patient with pancreaticoduodenectomy for adenocarcinoma of pancreas.
  
  
  METHODS
  Between 1985 and 1999, 183 patients were operated on for pancreatic adenocarcinoma. Among them, 63 patients (40 men, mean age 63 years, range 41-77 years) had curative resection and were included in this retrospective study. They were classified according to the type of resection. In the group I, the procedure included a pylorus-preserving pancreaticoduodenectomy (n = 35). In the group II, the procedure included polar inferior gastrectomy (n = 28). The prognosis was compared. Parameters for comparison were rate of local recurrence, rate of metastatic evolution and duration of survival.
  
  
  RESULTS
  The operative length and mortality rate (group I: 0%, group II: 3%), general (p = 0.37) and specific morbidity (p = 0.30), frequency of delayed gastric emptying were similar in the 2 groups (group I: 20%, group II: 35%, p = 0.88). The duration of naso-gastic aspiration was shorter in the group I (6 days vs 8, p = 0.01). The prognosis was the same in the 2 groups (metastasis: group I: 39%, group II: 56%, p = 0.12, local recurrence: group I: 58%, group II: 43%, p = 0.09, mean survival: group I: 18 months, group II: 19 months, p = 0.77).
  
  
  CONCLUSIONS
  These results suggest that pylorus preserving pancreatoduodenectomy could be performed for patients with adenocarcinoma of the head of the pancreas and does not compromise survival.
authors.affiliation: Service de chirurgie digestive, hôpital Sainte-Marguerite, 270, boulevard de Sainte-Marguerite, 13274 Marseille, France. nicolaspirro@yahoo.fr
authors.forename: N
authors.initials: N
authors.lastname: Pirro
authors.forename: I
authors.initials: I
authors.lastname: Sielezneff
authors.forename: J
authors.initials: J
authors.lastname: Cesari
authors.forename: B
authors.initials: B
authors.lastname: Consentino
authors.forename: R
authors.initials: R
authors.lastname: Gregoire
authors.forename: C
authors.initials: C
authors.lastname: Brunet
authors.forename: B
authors.initials: B
authors.lastname: Sastre
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology / Q000601:surgery*; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009017:Morbidity; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D010190:Pancreatic Neoplasms / Q000473:pathology / Q000601:surgery*; D016577:Pancreaticoduodenectomy / Q000379:methods*; D011183:Postoperative Complications; D011379:Prognosis; D011708:Pylorus / Q000601:surgery*; D012189:Retrospective Studies; D016019:Survival Analysis